Last updated on May 2019

Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With Thrombectomy

Brief description of study

The aim of this study is to find out if DS-1040b is safe and tolerable in acute ischemic stroke patients with thrombectomy. Four groups will receive different doses of DS-1040b by intravenous infusion for 6 hours. Groups with the lowest dose will start. When it is determined that each dose is safe and tolerable, the next higher dose will be given to the next group.

Clinical Study Identifier: NCT03198715

Find a site near you

Start Over